Diffusion Pharmaceuticals
Cash Flow
Last updated:
Cash flow statement presents a set of outflows and inflows of cash within a company through operating, investing and financing activities. Over the last year, operating activities of Diffusion Pharmaceuticals generated cash of -$14,969,114, which is less than the previous year. Cash used in financing activities reached the amount of $5,000 last year. Net change in cash is therefore -$27,199,852.
Cash Flow
| 2013 | -1.18M | 0 | 1.12M |
|---|---|---|---|
| 2014 | -9.03M | -50.91K | 30.70M |
| 2015 | -9.59M | -278.22K | 0 |
| 2016 | -10.76M | 8.49M | 1.82M |
| 2017 | -12.33M | -447.82K | 20.12M |
| 2018 | -10.77M | 0 | 9.86M |
| 2019 | -9.85M | 0 | 16.04M |
| 2020 | -13.55M | 0 | 17.89M |
| 2021 | -14.50M | 4K | 33.29M |
| 2022 | -14.96M | -12.23M | 5K |
DFFN Cash Flow Statement (2013 – 2022)
| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | |
|---|---|---|---|---|---|---|---|---|---|---|
Cash at beginning of period | 37.31M | 18.51M | 14.17M | 7.99M | 8.89M | 1.55M | 1.99M | 21.88M | 254.96K | 312.09K |
Operating activities | ||||||||||
Net income | -15.59M | -24.09M | -14.18M | -11.79M | -18.36M | -1.36M | -18.03M | -23.82M | -14.35M | -2.45M |
| Adjustments to reconcile net income to cash generated by operating activities: | ||||||||||
Depreciation and amortization | -208.57K | 93.41K | 103.16K | 97.91K | 110.37K | 67.98K | 25.34K | 23.26K | 566.26K | 675.75K |
Stock-based compensation expense | 928.05K | 897.26K | 736.11K | 515.76K | 1.22M | 1.24M | 1.39M | 2.09M | 1.60M | 262.81K |
| Deferred income tax benefit | 928.05K | 897.26K | 736.11K | 515.76K | 1.22M | 1.24M | 1.39M | 2.09M | 1.60M | 262.81K |
| Changes in operating assets and liabilities: | ||||||||||
Accounts receivable, net | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Inventories | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Accounts payable | -510.34K | 605.37K | 950.60K | 567.66K | -275.83K | -1.66M | 991.62K | -1.13M | -3.80M | 316.82K |
Cash generated by operating activities | -14.96M | -14.50M | -13.55M | -9.85M | -10.77M | -12.33M | -10.76M | -9.59M | -9.03M | -1.18M |
Investing activities | ||||||||||
Purchases Of Investments | -37.98M | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Investments In Property Plant And Equipment | 0 | 0 | 0 | 0 | 0 | -447.82K | -2.33K | -28.22K | -50.91K | 0 |
Acquisitions Net | 0 | 0 | 0 | 0 | 0 | 0 | 8.50M | -250K | 6.8M | 0 |
Cash generated by investing activities | -12.23M | 4K | 0 | 0 | 0 | -447.82K | 8.49M | -278.22K | -50.91K | 0 |
Financing activities | ||||||||||
Common Stock Issued | 5K | 31.09M | 10.82M | 12.31M | 10.84M | 50K | 1.40M | 0 | 31.84M | 427.50K |
Payments for dividends | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Repurchases of common stock | 0 | 0 | 0 | 0 | -428.54K | -125.98K | -54.34K | 0 | 0 | 0 |
Repayments of term debt | 0 | 0 | 0 | 0 | -550K | 0 | 0 | 0 | -1.54M | 0 |
Cash used in financing activities | 5K | 33.29M | 17.89M | 16.04M | 9.86M | 20.12M | 1.82M | 0 | 30.70M | 1.12M |
Net Change In Cash | -27.19M | 18.79M | 4.33M | 6.18M | -905.29K | 7.34M | -444.34K | -9.87M | 21.62M | -57.12K |
Cash at end of period | 10.11M | 37.31M | 18.51M | 14.17M | 7.99M | 8.89M | 1.55M | 12.00M | 21.88M | 254.96K |
| Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source | Data source |